Shares in Sun Pharmaceutical Industries gained 1.5 per cent after the company got US Food and Drug Administration approval to sell a drug to treat Osteoporosis, a bone-weakening disease.Currently the drug, Ibandronate Sodium, is marketed by Roche under the brand name Bovina.More players would be able to sell the drug after its patent expiry on September 2, 2014